Showing results (91-100 of 829) with videos related to

Sort By:
Pageof 83
Current Hypertension Reports|September 10, 2002
Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathyHans-Henrik Parving, Peter Hovind
Diabetes Care|March 12, 2008
Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rateAnne Sofie Astrup, Lise Tarnow, Lotte Pietraszek, et al.
Diabetologia|April 2, 2016
Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuriaBernt Johan von Scholten, Henrik Reinhard, Tine W Hansen, et al.
Platelets|August 13, 2010
Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney functionMaria Lajer, Inge Tarnow, Alan D Michelson, et al.
Kidney International|May 11, 2005
Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathySteen Andersen, Frans A van Nieuwenhoven, Lise Tarnow, et al.
Ugeskrift for Laeger|October 2, 2013
[Clinical use of estimated glomerular filtration rate for evaluation of kidney function]Bo Broberg, Morten Lindhardt, Peter Rossing, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2015
Number and frequency of albuminuria measurements in clinical trials in diabetic nephropathyTobias F Kröpelin, Dick de Zeeuw, Dennis L Andress, et al.
Diabetologia|July 28, 2014
Association of the pattern recognition molecule H-ficolin with incident microalbuminuria in an inception cohort of newly diagnosed type 1 diabetic patients: an 18 year follow-up studyJakob A Østergaard, Steffen Thiel, Peter Hovind, et al.
Diabetes Care|July 17, 2015
Increased all-cause mortality in patients with type 1 diabetes and high-expression mannan-binding lectin genotypes: a 12-year follow-up studyJakob A Østergaard, Steffen Thiel, Maria Lajer, et al.
Cardiovascular Diabetology|October 5, 2012
Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patientsHenrik Reinhard, Ellen Garde, Arnold Skimminge, et al.
Pageof 83